![954PProspective cohort study of bevacizumab plus standard platinum based chemotherapy as front-line treatment for advanced epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer: Japanese Gynecologic Oncology Group study (JGOG3022)]()
954PProspective cohort study of bevacizumab plus standard platinum based chemotherapy as front-line treatment for advanced epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer: Japanese Gynecologic Oncology Group study (JGOG3022)Kato, K.; Komiyama, S.; Takeshima, N.; Takano, H.; Inoue, A.; Hongo, A.; Asai-Sato, M.; Arakawa, A.; Kubushiro, K.; Kamiura, S.; Sugiyama, T. · Annals of Oncology · 2017